Valuation: Eckert & Ziegler SE

Market Cap 806M 901M 746M 675M 1.26B 85.75B 1.28B 8.97B 3.55B 44.85B 3.38B 3.31B 142B P/E 2026 *
15.7x
P/E 2027 * 14.9x
Enterprise Value 690M 772M 639M 578M 1.08B 73.44B 1.1B 7.68B 3.04B 38.41B 2.9B 2.84B 122B EV / Sales 2026 *
2.17x
EV / Sales 2027 * 2x
Free-Float
67.36%
Yield 2026 *
1.63%
Yield 2027 * 1.67%
1 day-1.45%
1 week-0.31%
Current month+1.10%
1 month+5.83%
3 months-3.16%
6 months-11.36%
Current year-15.60%
1 week 12.73
Extreme 12.73
13.37
1 month 11.91
Extreme 11.91
13.37
Current year 11.91
Extreme 11.91
16.84
1 year 11.91
Extreme 11.91
17.47
3 years 10.91
Extreme 10.913333
23.25
5 years 9.64
Extreme 9.639999
46.8
10 years 1.74
Extreme 1.740416
47.13
Manager TitleAgeSince
Chief Executive Officer 59 2023-06-06
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Operating Officer 59 2024-12-31
Director TitleAgeSince
Chairman 57 2023-06-06
Director/Board Member 66 2013-12-31
Director/Board Member 58 2016-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/26/24 Sell

Founder

6,720 0.0317%
3/26/24 Buy

Founder

6,720 0.0317%
8/30/23 Sell

Founder

48,000 0.2267%
Change 5-day change 1-year change 3-year change Capi.($)
-1.45%-0.31%-26.61%+10.09% 916M
+1.64%+0.81%+19.63%+55.60% 249B
+1.07%+3.81%+4.47%+20.29% 162B
-0.15%+4.26%-17.36%+74.03% 157B
-0.24%+1.18%-54.92%-8.44% 66.22B
-1.50%+0.44%+8.59%+67.34% 52.3B
+1.03%+3.07%-14.62%-8.28% 52.18B
+1.67%+3.83%+19.00%+44.25% 51.34B
+1.67%+3.57%+18.87%+68.69% 48.79B
+0.51%+5.00%+26.84%+86.53% 44.57B
Average +0.42%+2.16%-1.61%+41.01% 88.44B
Weighted average by Cap. +0.80%+1.41%+2.27%+46.10%

Financials

2026 *2027 *
Net sales 318M 356M 294M 266M 499M 33.83B 507M 3.54B 1.4B 17.7B 1.33B 1.31B 56.03B 342M 382M 316M 286M 536M 36.37B 545M 3.81B 1.51B 19.02B 1.43B 1.4B 60.23B
Net income 51.68M 57.79M 47.81M 43.29M 81.02M 5.5B 82.35M 575M 228M 2.88B 217M 212M 9.11B 53.08M 59.37M 49.11M 44.47M 83.23M 5.65B 84.59M 591M 234M 2.95B 223M 218M 9.35B
Net Debt -116M -129M -107M -96.97M -181M -12.32B -184M -1.29B -510M -6.44B -486M -476M -20.4B -123M -137M -113M -103M -192M -13.03B -195M -1.36B -539M -6.82B -514M -503M -21.58B
Projected Income Statement - Annual - Eckert & Ziegler SE
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Date Price Change Volume
26-10-26 €12.88 -1.45% 109,530
26-10-23 €13.07 -1.73% 67,048
26-10-22 €13.30 -0.15% 77,282
26-10-21 €13.32 +3.58% 161,038
26-10-20 €12.86 -0.46% 147,718
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Eckert & Ziegler SE
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.88EUR
Average target price
21.60EUR
Spread / Average Target
+67.70%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Eckert & Ziegler SE